Inhibition of DNA topoisomerase IIα gene expression by the p53 tumor suppressor

Molecular and Cellular Biology

Volumn 17, Issue 1, 1997, Pages 389-397

  Wang, Qingjian ^a,d   Zambetti, Gerard P ^b   Suttle, D Parker ^a,c  

^a UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA TOPOISOMERASE (ATP HYDROLYSING); PROTEIN P53;

AMINO ACID SEQUENCE; ARTICLE; CELL CYCLE S PHASE; CELL FUNCTION; DNA HELIX; DNA REPLICATION; DNA STRAND BREAKAGE; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

MURINAE;

EID: 0031014797     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.17.1.389     Document Type: Article

References (91)

1. Agarwal, M. L., A. Agarwal, W. R. Taylor, and G. R. Stark. 1995. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA 92:8493-8497.
2. Agoff, S. N., J. Hou, D. I. H. Linzer, and B. Wu. 1993. Regulation of the human hsp70 promoter by p53. Science 259:84-87.
3. Anderson, H., and M. Roberge. 1996. Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells. Cell Growth Differ. 7:83-90.
4. Bae, Y. S., I. Kawasaki, H. Ikeda, and L. F. Liu. 1988. Illegitimate recombination mediated by calf thymus DNA topoisomerase II in vitro. Proc. Natl. Acad. Sci. USA 85:2076-2080.
5. Baker, S. J., S. Markowitz, E. R. Fearon, J. K. V. Willson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915.
6. Bargonetti, J., P. N. Friedman, S. E. Kern, B. Vogelstein, and C. Prives. 1991. Wild-type but not mutant p53 immunopurified proteins bind to sequences adjacent to the SV40 origin of replication. Cell 65:1083-1091.
7. Berger, J. M., S. J. Gamblin, S. C. Harrison, and J. C. Wang. 1996. Structure and mechanism of DNA topoisomerase II. Nature 379:225-232.
8. Borellini, F., and R. I. Glazer. 1993. Induction of Sp1-p53 DNA-binding heterocomplexes during granulocyte/macrophage colony-stimulating factor-dependent proliferation in human erythroleukemia cell line TF-1. J. Biol. Chem. 268:7923-7928.
9. Caelles, C., A. Helmberg, and M. Karin. 1994. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370: 220-223.
10. Chen, A. Y., and L. F. Liu. 1994. DNA topoisomerases: essential enzymes and lethal targets. Annu. Rev. Pharmacol. Toxicol. 34:191-218.
11. Chernova, O. B., M. V. Chernov, M. L. Agarwal, W. R. Taylor, and G. R. Stark. 1995. The role of p53 in regulating genomic stability when DNA and RNA synthesis are inhibited. Trends Biochem. Sci. 20:431-434.
12. Chin, K.-V., K. Ueda, I. Pastan, and M. M. Gottesman. 1992. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 255:459-462.
13. Chiou, S.-K., L. Rao, and E. White. 1994. Bcl-2 blocks p53-dependent apoptosis. Mol. Cell. Biol. 14:2556-2563.
14. Cho, Y., S. Gorina, P. D. Jeffrey, and N. P. Pavletich. 1994. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265:346-355.
15. Cleveland, D. W., M. A. Lopata, R. J. MacDonald, N. J. Cowan, W. J. Rutter, and M. W. Kirschner. 1980. Number and evolutionary conservation of alpha-and beta-tubulin cytoplasmic beta-and gamma-actin genes using specific cloned cDNA probes. Cell 20:95-105.
16. Danks, M. K., C. A. Schmidt, M. C. Cirtain, D. P. Suttle, and W. T. Beck. 1988. Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26. Biochemistry 27:8861-8869.
17. Debbas, M., and E. White. 1993. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:546-554.
18. Del Sal, G., E. M. Ruaro, R. Utrera, C. N. Cole, A. J. Levine, and C. Schneider. 1995. Gas1-induced growth suppression requires a transactivation-independent p53 function. Mol. Cell. Biol. 15:7152-7160.
19. Di Leonardo, A., P. Cavolina, and A. Maddalena. 1993. DNA topoisomerase II inhibition and gene amplification in V79/B7 cells. Mutat. Res. 301:177-182.
20. DiNardo, S., K. Voelkel, and R. Sternglanz. 1984. DNA topoisomerase II mutant for Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication. Proc. Natl. Acad. Sci. USA 81:2616-2620.
21. Downes, C. S., D. J. Clarke, A. M. Mullinger, J. F. Gimenez-Abian, A. M. Creighton, and R. T. Johnson. 1994. A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells. Nature 372:467-470.
22. Drake, F. H., G. A. Hofmann, H. F. Bartus, M. R. Mattern, S. T. Crooke, and C. K. Mirabelli. 1989. Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry 28:8154-8160.
23. El-Deiry, W. S., S. E. Kern, J. A. Pietenpol, K. W. Kinzler, and B. Vogelstein. 1992. Definition of a consensus binding site for p53. Nat. Genet. 1:45-49.
24. El-Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
25. Fan, S., W. S. El-Deiry, I. Bae, J. Freeman, D. Jondle, K. Bhatia, A. J. Fornace, Jr., I. Magrath, K. W. Kohn, and P. M. O'Connor. 1994. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. Cancer Res. 54:5824-5830.
26. Fraser, D. J., T. L. Brandt, and D. J. Kroll. 1995. Topoisomerase II alpha promoter trans-activation early in monocytic differentiation of HL-60 human leukemia cells. Mol. Pharmacol. 47:696-706.
27. Giaccone, G., J. Van Ark-Otte, G. Scagliotti, G. Capranico, P. Van der Valk, G. Rubio, O. Dalesio, R. Lopez, F. Zunino, J. Walboomers, et al. 1995. Differential expression of DNA topoisomerases in non-small cell lung cancer and normal lung. Biochim. Biophys. Acta 1264:337-346.
28. Ginsberg, D., F. Mechta, M. Yaniv, and M. Oren. 1991. Wild-type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. USA 88:9979-9983.
29. Goswami, P. C., J. L. Roti Roti, and C. R. Hunt. 1996. The cell cycle-coupled expression of topoisomerase IIα during S phase is regulated by mRNA stability and is disrupted by heat shock and ionizing radiation. Mol. Cell. Biol. 16:1500-1508.
30. Graves, B. J., P. F. Johnson, and S. L. McKnight. 1986. Homologous recognition of a promoter domain common to the MSV LTR and the HSV tk gene. Cell 44:565-576.
31. Han, Y.-H., M. J. F. Austin, Y. Pommier, and L. F. Povirk. 1993. Small deletion and insertion mutations induced by the topoisomerase II inhibitor teniposide in CHO cells and comparison with sites of drug-stimulated DNA cleavage in vitro. J. Mol. Biol. 229:52-66.
32. Harris, C. C., and M. Hollstein. 1993. Clinical implication of the p53 tumor suppressor gene. N. Engl. J. Med. 329:1318-1327.
33. Harris, L. C., J. S. Remack, P. J. Houghton, and T. P. Brent. 1996. Wild-type p53 suppresses transcription of the human O6-methylguanine-DNA methyltransferase gene. Cancer Res. 56:2029-2032.
34. Harvey, D. M., and A. J. Levine. 1991. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev. 5:2375-2385.
35. Heck, M. M., and W. C. Earnshaw. 1986. Topoisomerase II: a specific marker for cell proliferation. J. Cell Biol. 103:2569-2581.
36. Heck, M. M., W. N. Hittelman, and W. C. Earnshaw. 1988. Differential expression of DNA topoisomerases I and II during the eukaryotic cell cycle. Proc. Natl. Acad. Sci. USA 85:1086-1090.
37. Hochhauser, D., C. A. Stanway, A. L. Harris, and I. D. Hickson. 1992. Cloning and characterization of the 5′-flanking region of the human topoisomerase II alpha gene. J. Biol. Chem. 267:18961-18965.
38. Horikoshi, N., A. Usheva, J. Chen, A. J. Levine, R. Weinmann, and T. Shenk. 1995. Two domains of p53 interact with the TATA-binding protein, and the adenovirus 13S E1A protein disrupts the association, relieving p53-mediated transcriptional repression. Mol. Cell. Biol. 15:227-234.
39. Ikeda, H. 1986. Bacteriophage T4 DNA topoisomerase mediates illegitimate recombination in vitro. Proc. Natl. Acad. Sci. USA 83:922-926.
40. Isaacs, R. J., A. L. Harris, and I. D. Hickson. 1996. Regulation of the human topoisomerase IIα gene promoter in confluence-arrested cells. J. Biol. Chem. 271:16741-16747.
41. Jeffrey, P. D., S. Gorina, and N. P. Pavletich. 1995. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms. Science 267:1498-1502.
42. Jenkins, J. R., P. Ayton, T. Jones, S. L. Davies, D. L. Simmons, A. L. Harris, D. Sheer, and I. D. Hickson. 1992. Isolation of cDNA clones encoding the b isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acids Res. 20:5587-5592.
43. Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991. Participation of p53 protein in the cellular response to DNA damage, Cancer Res. 51:6304-6311.
44. Kastan, M. B., Q. Zhan, W. S. El-Deiry, F. Carrier, T. Jacks, W. V. Walsh, B. S. Plunkett, B. Vogelstein, and A. J. Fornace, Jr. 1992. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell 71:587-597.
45. Kern, S. E., K. W. Kinzler, S. J. Baker, J. M. Nigro, V. Rotter, A. J. Levine, P. Friedman, C. Prives, and B. Vogelstein. 1991. Mutant p53 proteins bind DNA abnormally in vitro. Oncogene 6:131-136.
46. Kley, N., R. Y. Chung, S. Fay, J. P. Loeffler, and B. R. Seizinger. 1992. Repression of the basal c-fos promoter by wild-type p53. Nucleic Acids Res. 20:4083-4087.
47. Kubo, T., K. Kohno, T. Ohga, K. Taniguchi, K. Kawanami, M. Wada, and M. Kuwano. 1995. DNA topoisomerase IIα gene expression under transcriptional control in etoposide/teniposide-resistant human cancer cells. Cancer Res. 55:3860-3864.
48. Kuerbitz, S. J., B. S. Plunkett, W. V. Walsh, and M. B. Kastan. 1992. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA 89:7491-7495.
49. Lin, D., M. T. Shields, S. J. Ullrich, E. Appella, and W. E. Mercer. 1992. Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc. Natl. Acad. Sci. USA 89:9210-9214.
50. Lin, J., J. Chen, B. Elenbaas, and A. J. Levine. 1994. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev. 8:1235-1246.
51. Liu, X., C. W. Miller, P. H. Koeffler, and A. J. Berk. 1993. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription. Mol. Cell. Biol. 13:3291-3300.
52. Livingstone, L. R., A. White, J. Sprouse, E. Livanos, T. Jacks, and T. D. Tlsty. 1992. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923-935.
53. Loflin, P. T., D. Hochhauser, I. D. Hickson, F. Morales, and L. A. Zwelling. 1994. Molecular analysis of a potentially phorbol-regulatable region of the human topoisomerase IIα gene promoter. Biochem. Biophys. Res. Commun. 200:489-496.
54. Lowe, S. W., H. E. Ruley, T. Jacks, and D. E. Housman. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
55. Lu, H., and A. J. Levine. 1995. Human TAFII31 protein is a transcriptional coactivator of the p53 protein. Proc. Natl. Acad. Sci. USA 92:5154-5158.
56. Lu, X., and D. P. Lane. 1993. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 75:765-778.
57. Lum, L. S. Y., L. A. Sultzman, R. J. Kaufman, D. I. H. Linzer, and B. J. Wu. 1990. A cloned human CCAAT-box-binding factor stimulates transcription from the human hsp70 promoter. Mol. Cell. Biol. 10:6709-6717.
58. Mack, D. H., J. Vartikar, J. M. Pipas, and L. A. Laimins. 1993. Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 363:281-283.
59. Momand. J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245.
60. Ng, S.-W., J. P. Eder, L. E. Schnipper, and V. T. W. Chan. 1995. Molecular cloning and characterization of the promoter for the Chinese hamster DNA topoisomerase IIα gene. J. Biol. Chem. 270:25850-25858.
61. Nitiss, J. L. 1994. Roles of DNA topoisomerases in chromosomal replication and segregation. Adv. Pharmacol. 29A:103-134.
62. Okamoto, K., and D. Beach. 1994. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13:4816-4822.
63. Park, S. H., J. H. Yoon, H. A. Cho, Y. D. Kwon, R. H. Seong, S. H. Hong, and S. D. Park. 1995. Isolation and characterization of the promoter region of the rat DNA topoisomerase IIα gene. J. Biochem. 118:725-733.
64. Riou, G. F., M. Gabillot, M. Barrois, F. Breitburd, and G. Orth. 1985. A type-II DNA topoisomerase and a catenating protein from the transplantable VX2 carcinoma. Eur. J. Biochem. 146:483-488.
65. Sabbatini, P., S.-K. Chiou, L. Rao, and E. White. 1995. Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol. Cell. Biol. 15:1060-1070.
66. Sabbatini, P., J. Lin, A. J. Levine, and E. White. 1995. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev. 9:2184-2192.
67. Santhanam, U., A. Ray, and P. B. Sehgal. 1991. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 88:7605-7609.
68. Seto, E., A. Usheva, G. P. Zambetti, J. Momand, N. Horikoshi, R. Weinmann, A. J. Levine, and T. Shenk. 1992. Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA 89:12028-12032.
69. Shen, Y., and T. Shenk. 1994. Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein. Proc. Natl. Acad. Sci. USA 91:8940-8944.
70. Smith, K. A., P.A. Gorman, M. B. Stark, R. P. Groves, and G. R. Stark. 1990. Distinctive chromosomal structures are formed very early in the amplification of CAD genes in Syrian hamster cells. Cell 63:1219-1227.
71. Subler, M. A., D. W. Martin, and S. Deb. 1992. Inhibition of viral and cellular promoters by human wild-type p53. J. Virol. 66:4757-4762.
72. Thut, C. J., J. L. Chen, R. Klemm, and R. Tjian. 1995. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science 267:100-104.
73. Tishler, R. B., S. K. Calderwood, C. N. Coleman, and B. D. Price. 1993. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res. 53:2212-2216.
74. Truant, R., H. Xiao, C. J. Ingles, and J. Greenblatt. 1993. Direct interaction between the transcriptional activation domain of human p53 and the TATA box-binding protein. J. Biol. Chem. 268:2284-2287.
75. Tsai-Pflugfelder, M., L. F. Liu, A. A. Liu, K. M. Tewey, J. Whang-Peng, T. Knutsen, K. Huebner, C. M. Croce, and J. C. Wang. 1988. Cloning and sequencing of cDNA encoding human DNA topoisomerasc II and localization of the gene to chromosome region 17q21-22. Proc. Natl. Acad. Sci. USA 85:7177-7181.
76. Uemura, T., H. Ohkura, Y. Adachi, K. Morino, K. Shiozaki, and M. Yanagida. 1987. DNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe. Cell 50:917-925.
77. Vogelstein, B., and K. W. Kinzler. 1992. p53 function and dysfunction. Cell 70:523-526.
78. Wagner, A. J., J. M. Kokontis, and N. Hay. 1994. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev. 8:2817-2830.
79. Wang, J. C. 1985. DNA topoisomerases. Annu. Rev. Biochem. 54:665-697.
80. Wang, J. C. 1996. DNA topoisomerases. Annu. Rev. Biochem. 65:635-692.
81. Wang, J. C., P. R. Caron, and R. A. Kim. 1990. The role of DNA topoisomerases in recombination and genome stability: a double-edged sword. Cell 62:403-106.
82. Wang, Q., and R. Raghow. 1996. Okadaic acid-induced transcriptional down-regulation of type I collagen gene expression is mediated by protein phosphatase 2A. Mol. Cell. Biochem. 158:33-42.
83. Windle, B., B. W. Draper, Y. Yin, S. O'Gorman, and G. M. Wahl. 1991. A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes Dev. 5:160-174.
84. Woessner, R. D., M. R. Mattern, C. K. Mirabelli, R. K. Johnson, and F. H. Drake. 1991. Proliferation-and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ. 2:209-214.
85. Wu, X., J. H. Bayle, D. Olson, and A. J. Levine. 1993. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7:1126-1132.
86. Xiao, H., A. Pearson, B. Coulombe, R. Truant, S. Zhang, J. L. Regier, S. J. Triezenberg, D. Reinberg, O. Flores, C. J. Ingles, and J. Greenblatt. 1994. Binding of basal transcription factor TFIIH to the acidic activation domains of VP16 and p53. Mol. Cell. Biol. 14:7013-7024.
87. Yin, Y., M. A. Tainsky, F. Z. Bischoff, L. C. Strong, and G. M. Wahl. 1992. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-948.
88. Zambetti. G. P., J. Bargonetti, K. Walker, C. Prives, and A. J. Levine. 1992. Wild-type p53 mediates positive regulation of gene expression through a specific DNA sequence element. Genes Dev. 6:1143-1152.
89. Zambetti, G. P., and A. J. Levine. 1993. A comparison of the biological activities of wild-type and mutant p53. FASEB J. 7:855-865.
90. Zambetti, G. P., R. S. Quartin, J. Martinez, I. Georgoff, J. Momand, D. Dittmer, C. A. Finlay, and A. J. Levine. 1991. Regulation of transformation and the cell cycle by p53. Cold Spring Harbor Symp. Quant. Biol. 56:219-225.
91. Zhan, Q., S. Fan, I. Bae, C. Guillouf, D. A. Liebermann, P. M. O'Connor, and A. J. Fornace, Jr. 1994. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis. Oncogene 9:3743-3751.